내재형에 따른 비용종을 동반한 만성 비부비동염의 새로운 병태생리
New Discoveries Regarding Endotypes of Chronic Rhinosinusitis with Nasal Polyp
3
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Chronic rhinosinusitis (CRS) is a common chronic inflammatory disease of the nasal and paranasal mucosa and it usually affects substantial impaired quality of life. CRS is a highly heterogeneous disease and currently defined as subgroups of patients based on nasal endoscopic findings, accompanied either by CRS with nasal polyps (CRSwNP) or CRS without nasal polyps (CRSsNP). However, clinical phenotypes does not adequately reflect the pathophysiologic diversity within patients with CRS. Thus, CRS was also classified according to the inflammatory endotypes, which defined as subtypes of disease with an immunologically different from others by the involvement of a specific molecule or cell. To date, it has been well known that CRSsNP patients characterized by a predominant T helper cell type 1 inflammatory response, whereas CRSwNP patients from Western driven by a T helper cell type 2 inflammation and increased eosinophil infiltration. Meanwhile, CRSwNP patients from Asian displayed a mixed T cell profile with a non-eosinophilic inflammation pattern. However, recent some studies have reported the new discoveries regarding immunologic different endotypes of CRSwNP, such as innate lymphoid cells and activated B-cell mediated immune response. Therefore, herein we describe concepts and new discoveries of immunologic endotype in patients with CRSwNP. Korean J Otorhinolaryngol-Head Neck Surg 2017;60(9):431-6
Abstract
Chronic rhinosinusitis (CRS) is a common chronic inflammatory disease of the nasal and paranasal mucosa and it usually affects substantial impaired quality of life. CRS is a highly heterogeneous disease and currently defined as subgroups of patients based on nasal endoscopic findings, accompanied either by CRS with nasal polyps (CRSwNP) or CRS without nasal polyps (CRSsNP). However, clinical phenotypes does not adequately reflect the pathophysiologic diversity within patients with CRS. Thus, CRS was also classified according to the inflammatory endotypes, which defined as subtypes of disease with an immunologically different from others by the involvement of a specific molecule or cell. To date, it has been well known that CRSsNP patients characterized by a predominant T helper cell type 1 inflammatory response, whereas CRSwNP patients from Western driven by a T helper cell type 2 inflammation and increased eosinophil infiltration. Meanwhile, CRSwNP patients from Asian displayed a mixed T cell profile with a non-eosinophilic inflammation pattern. However, recent some studies have reported the new discoveries regarding immunologic different endotypes of CRSwNP, such as innate lymphoid cells and activated B-cell mediated immune response. Therefore, herein we describe concepts and new discoveries of immunologic endotype in patients with CRSwNP. Korean J Otorhinolaryngol-Head Neck Surg 2017;60(9):431-6
참고문헌 (34)
- Hastan D, "Chronic rhinosinusitis in Europe-an underestimated disease. A GA²LEN study", Allergy, 66(9), pp.1216~1223 (2011)
- Adams PF, "Summary health statistics for the U.S. population: national health interview survey, 2006", Vital Health Stat 10, (236), pp.1~104 (2008)
- 김도현, "Effect of Chronic Rhinosinusitis With or Without Nasal Polyp on Quality of Life in South Korea: 5th Korea National Health and Nutrition Examination Survey Korean", Clinical and Experimental Otorhinolaryngology, 9(2), pp.150~156 (2016), 대한이비인후과학회[DOI]
- Van Bruaene N, "T-cell regulation in chronic paranasal sinus disease", J Allergy Clin Immunol, 121(6), pp.1435~1441.e3 (2008)
- Zhang N, "Different types of T-effector cells orchestrate mucosal inflammation in chronic sinus disease", J Allergy Clin Immunol, 122(5), pp.961~968 (2008)
- Mjösberg JM, "Human IL-25- and IL-33-responsive type 2 innate lymphoid cells are defined by expression of CRTH2 and CD161", Nat Immunol, 12(11), pp.1055~1062 (2011)
- Moro K, "Innate production of TH2 cytokines by adipose tissue-associated c-Kit+Sca-1+ lymphoid cells", Nature, 463(7280), pp.540~544 (2010)
- Neill DR, "Nuocytes represent a new innate effector leukocyte that mediates type-2 immunity", Nature, 464(7293), pp.1367~1370 (2010)
- Spits H, "Innate lymphoid cells-a proposal for uniform nomenclature", Nat Rev Immunol, 13(2), pp.145~149 (2013)
- Hazenberg MD, "Human innate lymphoid cells", Blood, 124(5), pp.700~709 (2014)
- Hoyler T, "The transcription factor GATA-3 controls cell fate and maintenance of type 2 innate lymphoid cells", Immunity, 37(4), pp.634~648 (2012)
- Wong SH, "Transcription factor RORα is critical for nuocyte development", Nat Immunol, 13(3), pp.229~236 (2012)
- Allakhverdi Z, "CD34+ hemopoietic progenitor cells are potent effectors of allergic inflammation", J Allergy Clin Immunol, 123(2), pp.472~478 (2009)
- Onaka Y, "CRTH2, a prostaglandin D2 receptor, mediates depression-related behavior in mice", Behav Brain Res, 284, pp.131~137 (2015)
- Barlow JL, "Innate IL-13-producing nuocytes arise during allergic lung inflammation and contribute to airways hyperreactivity", J Allergy Clin Immunol, 129(1), pp.191~198.e4 (2012)
- Klein Wolterink RG, "Pulmonary innate lymphoid cells are major producers of IL-5 and IL-13 in murine models of allergic asthma", Eur J Immunol, 42(5), pp.1106~1116 (2012)
- Yoshida H, "Expression of α4β7 integrin defines a distinct pathway of lymphoid progenitors committed to T cells, fetal intestinal lymphotoxin producer, NK, and dendritic cells", J Immunol, 167(5), pp.2511~2521 (2001)
- Mebius RE, "Developing lymph nodes collect CD4+CD3- LTβ+ cells that can differentiate to APC, NK cells, and follicular cells but not T or B cells", Immunity, 7(4), pp.493~504 (1997)
- Kurschus FC, "Genetic proof for the transient nature of the Th17 phenotype", Eur J Immunol, 40(12), pp.3336~3346 (2010)
- Taube C, "IL-22 is produced by innate lymphoid cells and limits inflammation in allergic airway disease", PLoS One, 6(7), pp.e21799~ (2011)
- Kim HY, "Interleukin-17-producing innate lymphoid cells and the NLRP3inflammasome facilitate obesity-associated airway hyperreactivity", Nat Med, 20(1), pp.54~61 (2014)
- Cao PP, "Distinct immunopathologic characteristics of various types of chronic rhinosinusitis in adult Chinese", J Allergy Clin Immunol, 124(3), pp.478~484.e2 (2009)
- Ho J, "Group 2 innate lymphoid cells (ILC2s) are increased in chronic rhinosinusitis with nasal polyps or eosinophilia", Clin Exp Allergy, 45(2), pp.394~403 (2015)
- Miljkovic D, "Association between group 2 innate lymphoid cells enrichment, nasal polyps and allergy in chronic rhinosinusitis", Allergy, 69(9), pp.1154~1161 (2014)
- Julie A. Poposki, "Group 2 innate lymphoid cells are elevated and activated in chronic rhinosinusitis with nasal polyps", Immunity, Inflammation and Disease, 5(3), pp.233~243 (2017), Wiley-Blackwell[DOI]
- Shaw JL, "IL-33-responsive innate lymphoid cells are an important source of IL-13 in chronic rhinosinusitis with nasal polyps", Am J Respir Crit Care Med, 188(4), pp.432~439 (2013)
- Morita H, "Innate lymphoid cells in allergic and nonallergic inflammation", J Allergy Clin Immunol, 138(5), pp.1253~1264 (2016)
- Kim HY, "Innate lymphoid cells responding to IL-33 mediate airway hyperreactivity independently of adaptive immunity", J Allergy Clin Immunol, 129(1), pp.216~227.e6 (2012)
- Hulse KE, "Pathogenesis of nasal polyposis", Clin Exp Allergy, 45(2), pp.328~346 (2015)
- Yoon YH, "The role of B cell Activating Factor (BAFF) expression on pathogenesis of nasal polyp in chronic rhinosinusitis with nasal polyposis", Rhinology, 52(4), pp.390~396 (2014)
- Mackay F, "Cracking the BAFF code", Nat Rev Immunol, 9(7), pp.491~502 (2009)
- Tan BK, "Evidence for intranasal antinuclear autoantibodies in patients with chronic rhinosinusitis with nasal polyps", J Allergy Clin Immunol, 128(6), pp.1198~1206.e1 (2011)
- Peters AT, "Evidence for altered activity of the IL-6 pathway in chronic rhinosinusitis with nasal polyps", J Allergy Clin Immunol, 125(2), pp.397~403.e10 (2010)
- Van Zele T, "Local complement activation in nasal polyposis", Laryngoscope, 119(9), pp.1753~1758 (2009)